These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35738876)

  • 1. The anaphase-promoting complex/cyclosome co-activator, Cdh1, is a novel target of human papillomavirus 16 E7 oncoprotein in cervical oncogenesis.
    Jaiswal N; Nandi D; Cheema PS; Nag A
    Carcinogenesis; 2022 Nov; 43(10):988-1001. PubMed ID: 35738876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus type 16 E7 oncoprotein inhibits the anaphase promoting complex/cyclosome activity by dysregulating EMI1 expression in mitosis.
    Yu Y; Munger K
    Virology; 2013 Nov; 446(1-2):251-9. PubMed ID: 24074588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDH1 and SNAI1 are regulated by E7 from human papillomavirus types 16 and 18.
    Rosendo-Chalma P; Antonio-Vejar V; Bigoni-Ordóñez GD; Patiño-Morales CC; Cano-García A; García-Carrancá A
    Int J Oncol; 2020 Jul; 57(1):301-313. PubMed ID: 32319591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.
    Lu L; Hu S; Wei R; Qiu X; Lu K; Fu Y; Li H; Xing G; Li D; Peng R; He F; Zhang L
    J Biol Chem; 2013 Dec; 288(50):35637-50. PubMed ID: 24163370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk but not low-risk HPV E2 proteins bind to the APC activators Cdh1 and Cdc20 and cause genomic instability.
    Bellanger S; Blachon S; Mechali F; Bonne-Andrea C; Thierry F
    Cell Cycle; 2005 Nov; 4(11):1608-15. PubMed ID: 16222116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZER1 Contributes to the Carcinogenic Activity of High-Risk HPV E7 Proteins.
    Nouel J; White EA
    mBio; 2022 Dec; 13(6):e0203322. PubMed ID: 36346242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.
    Wang H; Feng K; Wang Q; Deng H
    Sci Rep; 2021 Jul; 11(1):14253. PubMed ID: 34244565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
    Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
    Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cdh1 is an antagonist of the spindle assembly checkpoint.
    Nagai M; Ushimaru T
    Cell Signal; 2014 Oct; 26(10):2217-22. PubMed ID: 25025567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation and disassembly of the anaphase-promoting complex during human cytomegalovirus infection is associated with degradation of the APC5 and APC4 subunits and does not require UL97-mediated phosphorylation of Cdh1.
    Tran K; Kamil JP; Coen DM; Spector DH
    J Virol; 2010 Oct; 84(20):10832-43. PubMed ID: 20686030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequestration of CDH1 by MAD2L2 prevents premature APC/C activation prior to anaphase onset.
    Listovsky T; Sale JE
    J Cell Biol; 2013 Oct; 203(1):87-100. PubMed ID: 24100295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TPR subunits of the anaphase-promoting complex mediate binding to the activator protein CDH1.
    Vodermaier HC; Gieffers C; Maurer-Stroh S; Eisenhaber F; Peters JM
    Curr Biol; 2003 Sep; 13(17):1459-68. PubMed ID: 12956947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
    Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
    Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of MCPH1 isoforms during mitosis followed by isoform-specific degradation by APC/C-CDH1.
    Meyer SK; Dunn M; Vidler DS; Porter A; Blain PG; Jowsey PA
    FASEB J; 2019 Feb; 33(2):2796-2808. PubMed ID: 30303738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LxCxD motif of the APC/C coactivator subunit FZR1 is critical for interaction with the retinoblastoma protein.
    Ramanujan A; Bansal S; Guha M; Pande NT; Tiwari S
    Exp Cell Res; 2021 Jul; 404(2):112632. PubMed ID: 33971196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate binding on the APC/C occurs between the coactivator Cdh1 and the processivity factor Doc1.
    Buschhorn BA; Petzold G; Galova M; Dube P; Kraft C; Herzog F; Stark H; Peters JM
    Nat Struct Mol Biol; 2011 Jan; 18(1):6-13. PubMed ID: 21186364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
    He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.
    Hatterschide J; Brantly AC; Grace M; Munger K; White EA
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained expression of HPV16 E7 oncoprotein promotes p-AKT(Ser473)/p-Src(Tyr527) signaling to drive precancerous lesions to invasive cervical cancer.
    Lin Z; Zhao Y; Li Q; Ci X; Ye X; Chen G; Tu Q; Feng W; Jiang P; Zhu S; Xue X; Saunders NA; Zhang L; Zhu X; Zhao KN
    Carcinogenesis; 2022 Jun; 43(5):479-493. PubMed ID: 35134836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular localization of the human papillomavirus 16 E7 oncoprotein in CaSki cells and its detection in cervical adenocarcinoma and adenocarcinoma in situ.
    Dreier K; Scheiden R; Lener B; Ehehalt D; Pircher H; Müller-Holzner E; Rostek U; Kaiser A; Fiedler M; Ressler S; Lechner S; Widschwendter A; Even J; Capesius C; Jansen-Dürr P; Zwerschke W
    Virology; 2011 Jan; 409(1):54-68. PubMed ID: 20970819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.